Intelligent Bio Solutions Inc. Announces Pricing for New Stock Offering
Intelligent Bio Solutions Inc. has made an important announcement regarding its recently priced underwritten public offering. This offering includes 1,304,348 shares of common stock priced at $2.00 per share, aiming for gross proceeds of approximately $2.6 million. This initiative is a significant step for the company, aiming to propel its mission of delivering advanced medical technology solutions.
Details of the Offering
The offering is being managed by Ladenburg Thalmann & Co. Inc., serving as the bookrunning manager. All shares in this offering are being sold directly by the Company, which also includes a 45-day option for the underwriter to purchase up to an additional 195,652 shares at the public offering price, minus underwriting discounts and commissions. The closing of this offering is contingent on customary closing conditions.
Purpose of the Proceeds
Intelligent Bio Solutions Inc. has outlined its intentions for utilizing the net proceeds from this offering. The funds are designated for working capital and general corporate purposes, which are critical for advancing the Company’s innovative testing technologies and sustaining its operations.
Company Profile
Headquartered in New York, Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a leader in the medical technology sector, recognized for its cutting-edge and rapid non-invasive testing solutions. The Company’s flagship product, the Intelligent Fingerprinting Drug Screening System, is positioned to revolutionize portable testing methodologies by leveraging innovative fingerprint sweat analysis. This technology has diverse applications, particularly in safety-sensitive workplaces, where it can efficiently screen for commonly used substances like opiates, cocaine, methamphetamine, and cannabis.
Testing Solutions for Various Industries
The rapid collection and analysis capabilities of Intelligent Bio Solutions’ testing systems allow results to be delivered in under ten minutes, enhancing response times for employers across various sectors. Their current customer segments include not only construction and manufacturing but also transport logistics, drug rehabilitation facilities, and law enforcement agencies.
Future Growth and Innovations
The commitment of Intelligent Bio Solutions Inc. extends beyond mere profitability; it encompasses a vision for holistic health solutions through innovative technologies. By continuously evolving its product line and exploring new market opportunities, the Company aims to contribute significantly to the health and wellness of society.
Frequently Asked Questions
What is the purpose of Intelligent Bio Solutions Inc.'s stock offering?
The proceeds from the stock offering will be used for working capital and other general corporate purposes.
Who is managing the stock offering?
Ladenburg Thalmann & Co. Inc. is the sole bookrunning manager for this offering.
What is the pricing of the shares in the offering?
The shares are priced at $2.00 each, with the offering aiming for approximately $2.6 million in gross proceeds.
What innovative technology does Intelligent Bio Solutions Inc. provide?
The Company provides the Intelligent Fingerprinting Drug Screening System, which uses non-invasive fingerprint sweat analysis for drug testing.
How can I contact Intelligent Bio Solutions Inc.?
You can reach out via email at info@ibs.inc for general inquiries or INBS@kcsa.com for media and investor relations.
